If you researched GLP-1 shots a year or two ago, you probably saw compounded semaglutide for $150 to $500 a month. That looked like a bargain next to Wegovy, which retails for about $1,000 to $1,300 a month. Here's the honest update as of mid-2026: those cheap compounded shots are mostly gone. The realistic path for most people is now brand-name Wegovy or Zepbound, and the good news is that the brand price has dropped a lot. (See our semaglutide guide.)
What Changed With Compounding
Compounded semaglutide is mixed by a pharmacy using the raw drug ingredient. During the 2023 to 2024 shortage, the FDA let compounding pharmacies make copies of Wegovy and Zepbound because the real thing was hard to get. That is why the low prices existed.
That window is closed. The shortage is over, and the FDA ended the special allowance in early 2025 (503A compounding pharmacies on February 18, 2025, and 503B outsourcing facilities on March 19, 2025). On April 30, 2026, the FDA proposed to permanently bar semaglutide, tirzepatide, and liraglutide from routine large-scale compounding. In plain terms: buying cheap compounded GLP-1s off a telehealth site is no longer a normal, legal option for most patients.
The One Narrow Exception
A pharmacy can still make a patient-specific version in limited cases, but only with a real medical reason. Examples include a documented allergy to an inactive ingredient in the brand product, or a dose that is not sold commercially. This is not a loophole for saving money. If a website offers you compounded semaglutide with no medical reason and no real exam, treat that as a red flag.
Cost Comparison (Mid-2026)
The gap between brand and compounded is not what it used to be, because the brand price fell.
- Retail Wegovy: about $1,000 to $1,300 per month without help.
- NovoCare self-pay pharmacy: $349 per month for the pens if you pay cash, or $149 for the Wegovy pill. Your first two pen fills run $199 through the end of 2026.
- Savings card: as little as $25 per month if you have commercial insurance that covers Wegovy.
- Compounded semaglutide: was about $150 to $500 per month during the shortage, but is no longer broadly available.
So the realistic comparison today is not "$300 compounded vs $1,300 brand." It is closer to "$149 to $349 brand cash price vs a compounded option most people can no longer legally get." That is a much smaller gap, and the brand comes with FDA oversight. (See our savings calculator and GLP-1 pricing guide.)
How to Make Brand-Name Affordable
You have more levers than you might think.
- Check your insurance first. If your plan covers Wegovy for weight loss, the savings card can bring your cost down to about $25 a month. See how insurance coverage works.
- Use the cash program if you are uninsured. NovoCare's self-pay pharmacy is the easiest way to get brand Wegovy for $149 to $349 a month, no insurance needed.
- Check Medicare. Since July 1, 2026, Medicare Part D covers Wegovy and Zepbound for obesity at a $50 monthly copay for people who qualify. Read our Medicare GLP-1 coverage guide.
- Ask about the pill. The oral semaglutide version of Wegovy launched in 2025. Whether it fits you depends on dose and cost. See pill vs injection.
For more ideas, read our tips on finding affordable GLP-1 clinics.
A Quick Note on Brands
It helps to keep the names straight. Wegovy and Zepbound are approved for weight loss. Ozempic and Mounjaro are the same drugs approved for type 2 diabetes. If cost is your main worry, focus on the weight-loss brands and their savings programs, not on tracking down a compounded copy.
Bottom Line
The cheap compounded era is basically over. Brand-name Wegovy is now the realistic choice, and between the cash program, the savings card, and new Medicare coverage, it is far more affordable than it was a year ago. Talk with a licensed provider about which option fits your health and your budget.
Find a GLP-1 clinic near you to compare prices and coverage, or browse clinics by state to see what's available in your area. (Not sure if you qualify? Try our BMI calculator.)